Litfulo (ritlecitinib)

**Product type:** Human Prescription Drug

**Active ingredient:** RITLECITINIB TOSYLATE

**Strength:** 50 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** U.S. Pharmaceuticals

**Marketing category:** NDA (NDA215830)

**Pharmacologic class:** Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Janus Kinase 3 Inhibitors [MoA], Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]